Main Article Content
Background: Phosphorus is an essential nutrient required for multiple physiological functions, recent researches found that high phosphorus intake could have detrimental effects on health. Hyperphosphatemia is one of the most important risk factors for morbidity and mortality for chronic kidney disease (CKD) patients. High phosphorus intake can cause vascular and renal calcification, renal tubular injury, and premature death in multiple animal models. Limited data exist linking high phosphorus intake directly to adverse clinical outcomes. Small studies in human suggest that high phosphorus intake may result in positive phosphorus balance and correlate with renal calcification and albuminuria.Further prospective studies are needed to determine whether phosphorus intake is a modifiable risk factor for kidney disease.
Aims & Objectives: To study the effect of dietary habits on dietary phosphorous intake in chronic kidney disease patients on hemodialysis.
To study the prevalence of hyperphosphatemia in patients of CKD on maintenance hemodialysis.
To see the impact of dietary control of phosphorus in CKD patients.
- This was a cross sectional comparative study. It was carrying in tertiary care centre in western region Maharashtra state.
- A total of 80 patient’s diagnosed case of CKD on maintenance of hemodialysis were selected for the study, patients on maintenance hemodialysis program twice in a week with 4 hour duration.
- Patients were divided into two groups as 1st group is on given diet to control phosphorus level in body and 2nd group is on phosphate binder to control phosphorus level.
- Baseline serum phosphorus was measured 1 month before hemodialysis and after 1 month prior hemodialysis in both group patients.
Results: It was observed that there was a significance difference between the pre and post phosphorus of group A(experimental group). The main difference was seen between age group 20-40 and 40-60, no difference was seen in age group 60-80. There was significant difference in pre and post phosphorus was also seen in group B, in group B age group 60-80 has shown good response.
Conclusion: Renal diet education can reduce phosphorus level and guided diet education provides an additional benefit on controlling hyperphosphatemia in haemodiaylsis patient. The purpose of the study is to see the effect of dietary habits on dietary phosphorus intake in CKD Patients on haemodialysis. Dietary counseling encourage the consumption of foods with least amount of inorganic or absorbable serum phosphorus, low phosphorus- to –protein ratio an adequate protein content .Our phosphorus additives list helps to reduce indirectly intake of phosphorus. Younger group of patient have followed renal diet for hyperphosphatemia effectively.
Raggi P, Kleerekoper M. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Clin J Am Soc Nephrol.2008;3(3):836-43.
Schwarz S, Trivedi BK, Kalantar-Zadeh K, Kovesdy CP. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol. 2006; 1(4):825–31.
Hruska KA, Mathew S, Laund R, Pratt R. Hyperphosphatemia Of chronic kidney disease.kidney Int 2008;74:148-158.
Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J. Phosphate ad- ditives in food--a health risk. Dtsch Arztebl Int. 2012;109(4):49–55.
Chauhan T. End-stage renal disease patients up nearly 19%. Canadian Medical Association Journal 2004;170(7):1087.
The Kidney Foundation of Canada. Facing the Facts - Winter 2009.
Available:http://www.kidney.ca/files/Kidney/aaFacing_the_Facts_Winter_2009_KRESCENT.pd. Accessed Mar 20, 2009.
Raphal, KL, ZhangY, Wei G, Green T, Cheung AK, Beddhu, S. Serum bicarbonate and mortality in adults in NHANES III. Nephrol Dial Transplant. 2013;28:1207-1213.
Goraya N, Wessona DE. Dietary interventions to improve outcomes in chronic kidney disease. Curr Opin. Nephrol Hypertens. 2015,24,505-510.
Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D, et al. Effect of food additives on hyperphosphatemia among patients with end stage renal disease: a randamozed controlled trial.JAMA 2013.
Kopple JD. Chapter 89. Renal Disorders and Nutrition. In: Shils ME, Olson JA, Shike M, Ross AC, editors. Modern nutrition in health and disease. 9th ed. Philadelphia, Pennsylvania:
Lumertgul D, Burke TJ, Gillum DM, Alfrey AC, Harris DC, Hammo nts with ESRD. Journal of the American Society of Nephrology 2005;16:S107-S114.
Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study. American Journal of Kidney Diseases 1998; 31(4):607-617.
Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. Journal of the American Society of Nephrology 2005;16:520-528.
Wexeler L, Brundage B, Crouse J, Detrano R, Fuster V, Maddhai J, et al. Coronary artery calcification: pathophy siology, epidemiology, imaging methods, and clinical implications. Circulation 1996; 94(1175-1192).
Morey B, Walker R, Davenport (). More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end‐stage kidney failure haemodialysis patients. Nephron Clinical Practice. 2008;109(3): c173– c180.
Cupist A D'Alessandro C, Baldi R, Barsotti G. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphos phatemia. Journal of Renal Nutrition 2004;14(4):220-225.
Kelly T, Suetonia C. Palmer, Shu Ning Wai, Marinella Ruospo, Juan-Jesus Carrero, Katrina L. Campbell, Giovanni F, Strippoli M. Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies jaimon. CJASN. 2017;12(2):272-279.